Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New EU project in the field of lipidomics promotes translational research towards human disease

21.08.2008
The enormous advances in biology and biomedical research during the last decade originate mainly from the fields of Genomics and Proteomics.

The current revolution in lipid analysis, however, promises change. For the first time the methodological possibilities are available to map the entire spectrum of lipids in cells, tissues and whole organisms.

Europe has so far played a pioneering and leading role in the biochemistry and analysis of lipids and most of the leading mass spectrometry providers are European companies. These mass spectrometry based nano-scale and high throughput technologies combined with molecular imaging and modern information technology will certainly revolutionize our understanding of the complex interaction networks in a functioning cell and how lipids together with genes and proteins determine cellular functions in health and disease.

Lipids are central to the regulation and control of cellular processes by acting as basic building units for biomembranes, the platforms for the vast majority of cellular functions. Recent developments in lipid mass spectrometry have set the scene for a completely new way to understand the composition of membranes, cells and tissues in space and time by allowing the precise identification and quantification of alterations of the total lipid profile after specific perturbations. In combination with advanced proteome and transcriptome analysis tools and novel imaging techniques using RNA interference, it is now possible to unravel the complex network between lipids, genes and proteins in an integrated lipidomics approach.

LipidomicNet addresses lipid droplets (LD) as dynamic organelles with regard to composition, metabolism and regulation. Lipid storage in multiple cells and tissues leads to transdifferentiation of multiple organs creating, fatty liver, obesity, white muscle and macrophage foam cells which are the hallmark of all energy overload diseases. LD also play a crucial role in HCV infection, a leading cause of liver disease that will continue to be a major health burden for the foreseeable future. This is why this organelle is in the focus of our project.

The project exploits recent advances in lipidomics technology to establish high-throughput methods to define drugable targets and novel biomarkers related to LD lipid and protein species, their interaction and regulation during assembly, disassembly and storage. The research groups study lipid protein interactions and investigate the dynamics of fat deposition and release in relevant cells as a hallmark of energy overload diseases with major health care impact in Europe.

Translational research from mouse to man applied to LD pathology is a cornerstone of this project at the interface between research and development. To maximize the value of the assembled data generated throughout the project, “LipidomicNet” (www.lipidomicnet.org) as a detailed special purpose Wiki format data base will be developed and integrated into the existing Lipidomics Expertise Platform (LEP) established through the SSA ELife project (www.lipidomics-expertise.de). ELife collaborates with the NIH initiative LIPID MAPS (www.lipidmaps.org) and the Japanese pendant Lipidbank (www.lipidbank.jp) and is connected to the Danubian Biobank consortium (SSA DanuBiobank, www.danubianbiobank.de) for clinical lipidomics.

LipidomicNet builds on a private public partnership (PPP) in order to support the translation of LipidomicNet inventions into new technologies and products that will benefit the health care systems. The 5 SMEs BIOBASE (www.biobase.de), ISB (www.systemsbiology.ru), ZORA Biosciences (www.zora.fi), Integromics (www.integromics.com) and Protagen (www.protagen.de) have been selected as PPP-partners between academia and industry because of their core competence necessary for LipidomicNet.

The EU-funded consortium of 21 European research groups and the 5 SMEs have recognized the utmost importance of promoting Lipidomic research, to attract the best young investigators to this newly forming research area to safeguard Europe’s vital interests in this important area and to ensure successful competition with the USA and Asia. Funding LipidomicNet in the field of Lipidomics will unequivocally be of benefit for areas such as health, nutrition and disease management.

Juergen Jonas | alfa
Further information:
http://www.lipidomicnet.org

Further reports about: HCV infection Lipidomic Mass spectrometry RNA interference fatty liver

More articles from Health and Medicine:

nachricht World first: Massive thrombosis removed during early pregnancy
20.07.2017 | Universitätsspital Bern

nachricht Therapy of preterm birth in sight?
19.07.2017 | Universitätsspital Bern

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Manipulating Electron Spins Without Loss of Information

Physicists have developed a new technique that uses electrical voltages to control the electron spin on a chip. The newly-developed method provides protection from spin decay, meaning that the contained information can be maintained and transmitted over comparatively large distances, as has been demonstrated by a team from the University of Basel’s Department of Physics and the Swiss Nanoscience Institute. The results have been published in Physical Review X.

For several years, researchers have been trying to use the spin of an electron to store and transmit information. The spin of each electron is always coupled...

Im Focus: The proton precisely weighted

What is the mass of a proton? Scientists from Germany and Japan successfully did an important step towards the most exact knowledge of this fundamental constant. By means of precision measurements on a single proton, they could improve the precision by a factor of three and also correct the existing value.

To determine the mass of a single proton still more accurate – a group of physicists led by Klaus Blaum and Sven Sturm of the Max Planck Institute for Nuclear...

Im Focus: On the way to a biological alternative

A bacterial enzyme enables reactions that open up alternatives to key industrial chemical processes

The research team of Prof. Dr. Oliver Einsle at the University of Freiburg's Institute of Biochemistry has long been exploring the functioning of nitrogenase....

Im Focus: The 1 trillion tonne iceberg

Larsen C Ice Shelf rift finally breaks through

A one trillion tonne iceberg - one of the biggest ever recorded -- has calved away from the Larsen C Ice Shelf in Antarctica, after a rift in the ice,...

Im Focus: Laser-cooled ions contribute to better understanding of friction

Physics supports biology: Researchers from PTB have developed a model system to investigate friction phenomena with atomic precision

Friction: what you want from car brakes, otherwise rather a nuisance. In any case, it is useful to know as precisely as possible how friction phenomena arise –...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Closing the Sustainability Circle: Protection of Food with Biobased Materials

21.07.2017 | Event News

»We are bringing Additive Manufacturing to SMEs«

19.07.2017 | Event News

The technology with a feel for feelings

12.07.2017 | Event News

 
Latest News

NASA looks to solar eclipse to help understand Earth's energy system

21.07.2017 | Earth Sciences

Stanford researchers develop a new type of soft, growing robot

21.07.2017 | Power and Electrical Engineering

Vortex photons from electrons in circular motion

21.07.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>